Myocarditis and pericarditis after COVID-19 vaccination is rare across demographic groups and most likely to occur in teen boys in the week after their second shot of a two-dose vaccine, according to a study.
As of Sept. 26, 81% of adults with ongoing symptoms of COVID lasting three months or longer -- or four out of five adults -- are experiencing limitations in their daily activities compared to before they had the virus.
Newswise — There is no evidence that the COVID-19 vaccination increases the incidence of Guillain-Barré syndrome, a rare neurological disorder in which the body’s immune system attacks the nerves, according to a Rutgers-led study.
Recent Comments